Cargando…

Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer’s and Parkinson’s Disease

Neurodegenerative diseases are the result of progressive dysfunction of the neuronal activity and subsequent neuronal death. Currently, the most prevalent neurodegenerative diseases are by far Alzheimer’s (AD) and Parkinson’s (PD) disease, affecting millions of people worldwide. Although amyloid pla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gutierrez, Berenice A., Limon, Agenor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313353/ https://www.ncbi.nlm.nih.gov/pubmed/35885050 http://dx.doi.org/10.3390/biomedicines10071743

Ejemplares similares

Disruption of Amyloid Plaques Integrity Affects the Soluble Oligomers Content from Alzheimer Disease Brains
por: Jimenez, Sebastian, et al.
Publicado: (2014)

Microtransplantation of Postmortem Native Synaptic mGluRs Receptors into Xenopus Oocytes for Their Functional Analysis
por: Miller, Brice, et al.
Publicado: (2022)

Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer’s Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers
por: Singh, Ayush, et al.
Publicado: (2020)

Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer’s disease neuropathologic change
por: Scaduto, Pietro, et al.
Publicado: (2022)

Altered synaptic structure in the hippocampus in a mouse model of Alzheimer’s disease with soluble amyloid-β oligomers and no plaque pathology
por: Price, Katherine A, et al.
Publicado: (2014)

Alzheimer’s Disease, Oligomers, and Inflammation
por: Forloni, Gianluigi, et al.
Publicado: (2018)

Increased excitatory to inhibitory synaptic ratio in parietal cortex samples from individuals with Alzheimer’s disease
por: Lauterborn, Julie C., et al.
Publicado: (2021)

Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease
por: Ferreira, Sergio T., et al.
Publicado: (2015)

Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease
por: Hector, Audrey, et al.
Publicado: (2021)

Ca(2+) Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer’s Disease
por: McDaid, John, et al.
Publicado: (2020)

Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease
por: Ding, Yu, et al.
Publicado: (2019)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
por: Tsigelny, Igor F., et al.
Publicado: (2008)

How do Soluble Oligomers of Amyloid β-protein Impair Hippocampal Synaptic Plasticity?
por: Li, Shaomin, et al.
Publicado: (2010)

Amyloid β-protein oligomers and Alzheimer’s disease
por: Hayden, Eric Y, et al.
Publicado: (2013)

Early diagnosis and treatment of Alzheimer’s disease by targeting toxic soluble Aβ oligomers
por: Habashi, Maram, et al.
Publicado: (2022)

SOBA (soluble oligomer binding assay): A breakthrough or the early diagnosis of Alzheimer's disease
por: Sheikh, Ayesha, et al.
Publicado: (2023)

Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer’s Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression
por: Tolar, Martin, et al.
Publicado: (2021)

Alzheimer’s disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory
por: Klyubin, Igor, et al.
Publicado: (2012)

Environmental Factors Preceding Aβ40 Monomer to Oligomers and the Detection of Oligomers in Alzheimer's Disease Patient Serum
por: Matsunaga, Yoichi, et al.
Publicado: (2012)

Selected microRNAs Increase Synaptic Resilience to the Damaging Binding of the Alzheimer’s Disease Amyloid Beta Oligomers
por: Zolochevska, Olga, et al.
Publicado: (2020)

Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer’s disease
por: Peris, Leticia, et al.
Publicado: (2022)

An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?
por: Sciaccaluga, Miriam, et al.
Publicado: (2021)

Neuropathological and Biomarker Findings in Parkinson’s Disease and Alzheimer’s Disease: From Protein Aggregates to Synaptic Dysfunction
por: Compta, Yaroslau, et al.
Publicado: (2021)

Introduction of Tau Oligomers into Cortical Neurons Alters Action Potential Dynamics and Disrupts Synaptic Transmission and Plasticity
por: Hill, Emily, et al.
Publicado: (2019)

Transcriptional and bioinformatic analysis of GABA(A) receptors expressed in oligodendrocyte progenitor cells from the human brain
por: Gutierrez, Berenice A., et al.
Publicado: (2023)

Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease
por: Baglietto‐Vargas, David, et al.
Publicado: (2018)

Reply: Soluble oligomers or insoluble fibrils?
por: Mate de Gerando, Anastasie, et al.
Publicado: (2023)

Hypothesis: Soluble Aβ Oligomers in Association with Redox-Active Metal Ions Are the Optimal Generators of Reactive Oxygen Species in Alzheimer's Disease
por: Tabner, Brian J., et al.
Publicado: (2010)

Preservation of global synaptic excitatory to inhibitory ratio during long postmortem intervals
por: Scaduto, Pietro, et al.
Publicado: (2020)

Cholesterol in the Pathogenesis of Alzheimer’s, Parkinson’s Diseases and Autism: Link to Synaptic Dysfunction
por: Petrov, A. M., et al.
Publicado: (2017)

Alzheimer Amyloid-β Oligomer Bound to Post-Synaptic Prion Protein Activates Fyn to Impair Neurons
por: Um, Ji Won, et al.
Publicado: (2012)

β-Amyloid oligomers in aging and Alzheimer’s disease
por: Zahs, Kathleen R., et al.
Publicado: (2013)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

c-Abl Deficiency Provides Synaptic Resiliency Against Aβ-Oligomers
por: Gutierrez, Daniela A., et al.
Publicado: (2019)

Synaptic and cellular plasticity in Parkinson’s disease
por: Chu, Hong-Yuan
Publicado: (2020)

Detection of Soluble Amyloid-β Oligomers and Insoluble High-Molecular-Weight Particles in CSF: Development of Methods with Potential for Diagnosis and Therapy Monitoring of Alzheimer's Disease
por: Funke, Susanne Aileen
Publicado: (2011)

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
por: Mroczko, Barbara, et al.
Publicado: (2018)

The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer’s Disease (AD)
por: Mroczko, Barbara, et al.
Publicado: (2019)

Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn(2+) in cognitively intact aged individuals with Alzheimer’s disease neuropathology
por: Bjorklund, Nicole L, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9do6q68jfbmtds5m0gdu3ncrs3